Rigel Pharmaceuticals Inc (RIGL) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
Rigel Pharmaceuticals Inc (RIGL) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($21.98 Million) in capital expenditures ($12.00K). See Rigel Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$21.98 Million
USD
Capital Expenditures
$12.00K
USD
Data as of
Dec 2025
Most recent filing
Rigel Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2024)
This chart tracks Rigel Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Rigel Pharmaceuticals Inc (2010–2024)
Year-by-year Capital Reinvestment Ratio for Rigel Pharmaceuticals Inc from 2010 to 2024. For live market cap and broader valuation context, see market value of Rigel Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $31.47 Million | $396.00K | ▼ -88.2% |
| 2021 | 0.11x | $5.88 Million | $627.00K | ▲ +40.1% |
| 2010 | 0.08x | $46.74 Million | $3.56 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow